Erasca, Inc. License Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive License Agreement, dated March 12, 2020, by and between Katmai Pharmaceuticals, Inc. and the Registrant
License Agreements
Erasca, Inc.
Biotechnology
DE
2021
License Agreement, dated May 14, 2024, by and between Medshine Discovery Inc., and Erasca, Inc
License Agreements
Erasca, Inc.
2024
License Agreement, dated May 15, 2024, by and between Guangzhou Joyo Pharmatech Co., Ltd., and Erasca, Inc
License Agreements
Erasca, Inc.
2024
First Amendment to Exclusive License Agreement, dated August 7, 2023, by and between Novartis Pharma AG and the Registrant
License Agreements
Erasca, Inc.
2023
Amended and Restated License Agreement, dated November 23, 2020, by and among the Registrants wholly-owned subsidiaries, ASN Product Development, Inc. and Asana BioSciences, LLC
License Agreements
Erasca, Inc.
Biotechnology
NY
2021
License Agreement, dated February 18, 2020, by and between NiKang Therapeutics, Inc. and the Registrant
License Agreements
Erasca, Inc.
Biotechnology
CA
2021
Exclusive License Agreement, dated December 21, 2018, by and between The Regents of the University of California and the Registrant, as amended
License Agreements
Erasca, Inc.
Biotechnology
DE
2021